11
Views
1
CrossRef citations to date
0
Altmetric
Research Article

Rituximab in Lymphoma with Life Threatening Haemolysis

&
Pages 1711-1712 | Published online: 01 Jul 2009

  • McLaughlin, P., Grillo-Lopez, A. and Link, B. (1998) "Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a 4-dose treatment regimen". Journal of Clinical Oncology 16, 2825-2833.
  • Vose, J.M. (1999) "Antibody-targeted therapy for low-grade lymphoma". Seminars in Hematalogy 36(4 Suppl. 6), 15-20.
  • Press, O.W. (2000) Innovative New Therapies for Non-Hodgkin's Lymphoma: Monoclonal Antibodies and Immunoconjugates (ASCO Educational Book), pp 328-337.
  • Thomas, A. (2000) "Rituximab anti-CD20 monoclonal antibody therapy in non-hodgkin's lymphoma: safety and efficacy of retreatment". Journal of Clinical Oncalogy 18, 3135-3143

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.